Tran Nguyen's Net Worth
$11.5 Million
Who is Tran Nguyen?
Tran Nguyen has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include Rain Oncology Inc., PROTHENA CORP PUBLIC LTD CO, Sierra Oncology, Inc., Pernix Sleep, Inc., and METABASIS THERAPEUTICS INC.
SEC CIK
Tran Nguyen's CIK is 0001457013
Past Insider Trading and Trends
2022 was Tran Nguyen's most active year for acquiring shares with 10 total transactions. Tran Nguyen's most active month to acquire stocks was the month of January. 2022 was Tran Nguyen's most active year for disposing of shares, totalling 24 transactions. Tran Nguyen's most active month to dispose stocks was the month of December. 2023 saw Tran Nguyen paying a total of $2,685,850.00 for 208,000 shares, this is the most they've acquired in one year. In 2023 Tran Nguyen cashed out on 250,000 shares for a total of $8,601,939.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Rain Oncology Inc. (RAIN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $26.67
Chief Strategy Officer and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
$50.07 | -$4,544,971.49 | 3.2K |
May 17
| |||
Form 4
|
—
|
0
|
$27.58 | -$417,014.21 | 3.2K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$30.04 | -$466,097.21 | 3.2K |
Scheduled
|
Feb 15
| ||
Form 4
|
—
|
0
|
$31.13 | -$488,006.42 | 3.2K |
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
$32.85 | -$522,390.23 | 3.2K |
Scheduled
|
Dec 21
| ||
Form 4
|
—
|
0
|
$33.91 | -$543,553.56 | 3.2K |
Scheduled
|
Nov 23
| ||
Form 4
|
—
|
0
|
$31.59 | -$497,085.30 | 3.2K |
Scheduled
|
Oct 19
| ||
Form 4
|
—
|
0
|
$18.74 | -$240,196.00 | 3.2K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
$18.45 | -$234,372.00 | 3.2K |
Scheduled
|
Aug 24
| ||
Form 4
|
—
|
0
|
$19.63 | -$1,806,688.16 | 3.2K |
Scheduled
|
Jul 20 - Jul 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +45.45% | 1K |
$51.32 | $51,317.20 | 3.2K |
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
$36.45 | -$1,783,075.12 | 2.2K |
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
∞
| 2.2K |
$19.61 | $43,134.08 | 2.2K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pernix Sleep, Inc. No price found
SVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -42.42K |
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +2.21% | 1.08K |
$3.08 | -$1,268.96 | 49.95K |
Scheduled
|
Dec 31 - Jan 2
| ||
Form 4
| +132.64% | 30K |
—
|
—
| 52.62K |
Nov 16
| |||
Form 4
| +11.62% | 15.72K |
—
|
—
| 150.94K |
Sep 30
| |||
Form 4
| +13.41% | 15.99K |
—
|
—
| 135.22K |
Jul 2
| |||
Form 4
| -2.69% | -3.30K |
$0.48 | -$1,574.76 | 119.23K |
Scheduled
|
Jan 3
| ||
Form 4
| -3.07% | -3.30K |
$2.84 | -$9,360.12 | 104.2K |
Scheduled
|
Apr 12
| ||
Form 4
| +290.91% | 80K |
—
|
—
| 107.5K |
Mar 7
| |||
Form 4
| +10.00% | 2.5K |
$3.89 | $9,725.00 | 27.5K |
Sep 15
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
METABASIS THERAPEUTICS INC No price found
VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |